Actively Recruiting
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Led by Erasmus Medical Center · Updated on 2024-03-20
700
Participants Needed
2
Research Sites
321 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The I-FILE study is a prospective multicenter, multinational observational study where the feasibility of a patient-led registry using home monitoring in patients with pulmonary fibrosis will be evaluated. The aim of the study is to gain more insights in disease behavior in patients with pulmonary fibrosis, so in future patients with progressive disease can be better identified.
CONDITIONS
Official Title
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed patients with fibrotic interstitial lung disease according to ATS/ERS criteria by a multidisciplinary ILD team
- Diagnosis made within 6 months before inclusion
- Treatment for fibrotic interstitial lung disease started 1 month ago or less
You will not qualify if you...
- Unable to speak, read, or write in the native language where the patient is included
- Unable to follow the study protocol as judged by the investigator or patient
- No access to the internet
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015 CE
Actively Recruiting
2
Erasmus MC
Rotterdam, Netherlands
Actively Recruiting
Research Team
M
Marlies Wijsenbeek, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here